Associated Papers
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
Vergani E et al.
Genes, 2021
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
Pellegrini C et al.
The Lancet. Child & Adolescent Health, 2019
In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants.
Hernando B et al.
Pigment Cell & Melanoma Research, 2019
Update in genetic susceptibility in melanoma.
Potrony M et al.
Annals of Translational Medicine, 2015
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Puntervoll HE et al.
Journal of Medical Genetics, 2013
Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants.
Ozola A et al.
Cancer Genetics, 2013
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F et al.
Journal of the National Cancer Institute, 2010
CDKN2A mutations in melanoma families from Uruguay.
Larre Borges A et al.
The British Journal of Dermatology, 2009
Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML et al.
Experimental Dermatology, 2009
Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B et al.
Bmc Medical Genetics, 2008
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM et al.
International Journal of Cancer, 2007
MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population.
Fernandez L et al.
Carcinogenesis, 2007
High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.
Hocevar M et al.
Croatian Medical Journal, 2006
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Kanetsky PA et al.
Cancer Research, 2006
Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
Stratigos AJ et al.
The Journal of Investigative Dermatology, 2006
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Chaudru V et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2005
Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2005
CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma.
Peris K et al.
The Journal of Investigative Dermatology, 2004
Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi.
Papp T et al.
Journal of Medical Genetics, 2003
Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi.
Papp T et al.
Journal of Medical Genetics, 1999